The role of apoptotic cell death in cardiovascular disease

Irish Journal of Medical Science

Volumn 170, Issue 2, 2001, Pages 132-140

  McLaughlin, R ^a   Kelly, C J ^a   Kay, E ^a   Bouchier Hayes, D ^a  

^a BEAUMONT HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NITRIC OXIDE; PROTEIN BCL 2; PROTEIN P53; TUMOR NECROSIS FACTOR;

APOPTOSIS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; CELL DEATH; CONTROLLED STUDY; DISEASE COURSE; ENDOTHELIUM; ENERGY; GENE CONTROL; HEART FAILURE; HEART MUSCLE ISCHEMIA; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; MEDICAL LITERATURE; NECROSIS; PATHOGENESIS; PUBLICATION; REPERFUSION INJURY; REVIEW; SYNDROME; THERAPY;

EID: 0034894232     PISSN: 00211265     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03168827     Document Type: Review

References (145)

1. Apoptosis: A basic biological phenomenon with wide ranging implications in tissue cell kinetics
2. Stretch induced programmed myocyte cell death
3. The cellular basis of dilated cardiomyopathy in humans
4. Acute myocardial infarction in humans is associated with activation of programmed myocyte cell death in the surviving portion of the heart
5. Apoptosis: An overview
6. Cytological and cytochemical studies on cell death and digestion in the foetal rat foot: The role of macrophages and hydrolytic enzymes
7. Cell death by apoptosis and its protective role against disease
8. Apoptosis and carcinogenesis
9. Programmed cell death: Apoptosis and oncogenesis
10. The role of apoptosis in the response of cells and tumours to mild hyperthermia
11. Programmed cell death: Apoptosis and oncogenesis
12. Activation of programmed cell death (apoptosis) by cisplatin, other anti-cancer drugs and hyperthermia
13. The importance of oxidative stress in apoptosis
14. Reperfusion injury induces apoptosis in rabbit cardiomyocytes
15. Apoptosis in the heart
16. Apoptosis and the failing human heart
17. Myocyte nuclear and possible cellular hyperplasia contribute to ventricular remodeling in the hypertrophic senescent heart in humans
18. Apoptotic and necrotic cell deaths are independent contributing variables of infarct size in rats
19. Apoptosis is abundant in human atherosclerotic lesions especially in inflammatory cells and may contribute to the accumulation of gruel and plaque instability
20. Apoptosis in human atherosclerosis and restenosis
21. Apoptosis in the infarcted human heart
22. Apoptosis; The role of the endonuclease
23. Tumour necrosis factor alpha induced apoptosis in cardiac myocytes
24. Microelectrophoretic study of radiation induced DNA damage in mammalian cells
25. The comet assay: A comprehensive review
26. The cell cycle related differences in susceptibility of HL-60 cells to apoptosis induced by various antitumor agents
27. Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques
28. Events in apoptosis. Acidification is downstream of protease activation and BCL-2 protection
29. Preconditioning protects ischemic rabbit heart by protein kinase C activation
30. Preconditioning rabbit cardiomyocytes: Role of pH, vacuolar proton ATPase, and apoptosis
31. Role of translocases in the generation of phosphatidylserine asymmetry
32. Different populations of macrophages use either the vitronectin receptor or the phosphatidylserine receptor to recognise and remove apoptotic cells
33. Exposure of phosphatidylserine on the surface of lymphocytes triggers specific recognition and removal by macrophages
34. Binding of vascular anticoagulant to planar phospholipid bilayers
35. Thrombin generation by apoptotic vascular smooth muscle cells
36. Studies on cell agony and death: An attempt at classification
37. Death of a cell
38. Inflammation in the course of early myocardial ischemia
39. Apoptosis in the pathogenesis and treatment of disease
40. Apoptosis in myocytes in end stage heart failure
41. The ins and outs of programmed cell death during C. Elegans development
42. Genetic control of programmed cell death in the nematode C. elegans
43. C. elegans survival gene ced-9 encodes a functional homologue of the mammalian proto-oncogene bcl-2
44. Purification of a 24-kD protease from apoptosis tumour cells that activates DNA fragmentation
45. Caspase activation is required for commitment to Fas-mediated apoptosis
46. Signal transduction by DR3, a death domain containing receptor related to TNFR1 and CD95
47. FADD, a novel death domain containing protein interacts with the death domain of Fas and initiates apoptosis
48. A death domain containing receptor that mediates apoptosis
49. The receptor for the cytotoxic ligand TRAIL
50. Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis
51. The BCL-2 family of proteins
52. Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation
53. Genetic control of programmed cell death in the nematode C. elegans
54. Constitutive expression of human bcl-2 modulates nitrogen mustard and campothecin induced apoptosis
55. Bcl-2 oncoprotein blocks chemotherapy induced apoptosis in a human leukemic cell line
56. Programmed cell death and expression of the proto-oncogene bcl-2 in myocytes during post-natal maturation of the heart
57. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerisation with Bax
58. Induction of apoptotic program in cell free extracts: Requirements for dATP and cytochrome c
59. Mitochondrial control of nuclear apoptosis
60. Molecular ordering of the cell death pathway: Bcl-2 and bcl-xl function upstream of the CED-3 like apoptotic proteases
61. Fas induced activation of the cell death related protease CPP32 is inhibited by Bcl-2 and by ICE family proteases
62. Bcl-2 inhibits the mitochondrial release of an apoptogenic protease
63. The release of cytochrome c from mitochondria: A primary site for Bcl-2 regulation of apoptosis
64. Bcl-2 functions in an anti-oxidant pathway to prevent apoptosis
65. Programmed cell death and bcl-2 protection in very low oxygen
66. Prevention of hypoxia induced cell death by bcl-2 and bcl-XL
67. Bik, a novel death inducing protein shares a distinct structural motif with bcl-2 family proteins and interacts with viral and cellular survival promoting proteins
68. Molecular thanatopsis: A discourse on the bcl-2 family and cell death
69. Regulation of apoptosis by bcl-2 family proteins and its role in cancer and chemoresistance
70. Checkpoints of dueling dimers foil cell death
71. Evidence for the rapid onset of apoptosis in medial smooth muscle cells after balloon injury
72. Stabilised p53 facilitates ancuploid clonal divergence in colorectal cancer
73. p53 and the hypoxia induced apoptosis of cultured neonatal rat cardiac myocytes
74. Adenovirus E1A represses cardiac gene transcription and reactivates DNA synthesis in ventricular cardiomyocytes, via alternate pocket protein and p300 binding domains
75. Adenoviral delivery of E2F-1 directs cell cycle re-entry and p53 independent apoptosis in post-mitotic adult cardiomyocytes in vitro
76. Myocyte apoptosis during acute myocardial infarction in the mouse localizes to hypoxic regions but occurs independently of p53
77. The bcl-2 gene product prevents programmed cell death of ventricular myocytes
78. Regulators of apoptosis in the heart: A matter of life or death
79. The discovery of endothelium-derived relaxing factor and its importance in the identification of nitric oxide
80. The role of chemical mediators released by the endothelium in the control of the cardiovascular system
81. Nitric oxide synthases and cardiac muscle: Autocrine and paracrine influences
82. Induction of myocardial nitric oxide synthase by cardiac allograft rejection
83. Cellular and molecular cardiovascular disease: Apoptosis of cardiac myocytes during cardiac allograft rejection: Relation to induction of nitric oxide synthase
84. The lethal effects of cytokine induced nitric oxide in cardiac myocytes are blocked by nitric oxide synthase antagonism or transforming growth factor beta
85. In vivo gene transfection of human endothelial cell nitric oxide synthase in cardiomyocytes causes apoptosis like cell death; Identification using Sendai virus coated particles
86. Nitric oxide attenuates vascular smooth muscle activation by interferon gamma
87. Mechanisms and genes of cellular suicide
88. Vascular smooth muscle cells express a constitutive NF-kB like activity
89. NF-kB is induced in the nuclei of cultured rat aortic smooth muscle cells by stimulation of various growth factors
90. Expression of an NF-kB like activity is essential for proliferation of cultured bovine vascular smooth muscle cells
91. Activated transcription factor nuclear factor-kB is present in the atherosclerotic lesion
92. Expression of NF-kB and Ik-B by aortic endothelium in an arterial injury model
93. Tumour necrosis factor can induce both apoptotic and necrotic forms of cell lysis
94. Evidence of cardiocyte apoptosis in myocardium of dogs with chronic heart failure
95. Tumour necrosis factor-(and tumour necrosis factor receptor in the failing human heart
96. Apoptosis in congestive heart failure induced by viral myocarditis in mice
97. Apoptosis and DNA fragmentation in the bulbis cordis of the developing rat heart
98. Normal and abnormal consequences of apoptosis in the human heart: From post-natal morphogenesis to paroxysmal arrhythmias
99. Apoptosis in arteries of the neonatal lamb
100. The tunica media in aging rats
101. Evidence for apoptosis in human atherogenesis and in a rat vascular injury model
102. Contributions of ischaemia and reperfusion to mucosal lesion formation
103. Does reperfusion injury exist in humans
104. Stretch induced programmed myocyte cell death
105. Forging a path to cell death
106. Basic mechanisms in heart failure: The cytokine hypothesis
107. Apoptosis in human myocardial infarction
108. Overexpression of manganese superoxide dismutase promotes the survival of tumour cells exposed to interleukin 1, tumour necrosis factor selected anti-cancer drugs and ionising radiation
109. Oxidative stress induced apoptosis prevented by Trolox
110. Cellular mechanisms of endothelial cell death during the systemic inflammatory response syndrome
111. Apoptosis in pressure overload induced heart hypertrophy in the rat
112. Apoptosis in target organs of hypertension
113. Stretch mediated release of angiotensin II induces myocyte apoptosis by activating p53 that enhances the local renin angiotensin system and decreases the bcl-2 to bax protein ratio in the cell
114. Angiotensin II induces apoptosis of adult ventricular myocytes in vitro
115. Evidence of apoptosis in arrhythmogenic right ventricular failure
116. Cytokine mRNA expression in post-ischaemic/reperfused myocardium
117. Serum interleukin-6 levels become elevated in acute myocardial infarction
118. Elevated circulating levels of tumour necrosis factor-alpha in severe chronic heart failure
119. Oxidative stress activates extracellular signal-regulated kinases through src and ras in cultured cardiac myocytes of neonatal rats
120. Myocardial reperfusion injury: Role of oxygen radicals and potential therapy with anti-oxidants
121. Evidence for apoptosis in advanced human atheroma: Co-localization with interleukin-1-(-converting enzyme
122. Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques
123. Necrosis and apoptosis induced by oxidized low density lipoproteins occurs through two calcium dependant pathways in lymphoblastoid pathways
124. Role of oxidized low density lipoprotein in atherogenesis
125. The oxidation hypothesis of atherosclerosis
126. Suppression of apoptosis by nitric oxide via inhibition of interleukin-1beta converting enzyme(ICE)-like and cysteine protease protein (CPP)-32-like proteases
127. L-arginine prevents xanthoma development and inhibits atherosclerosis in LDL receptor knockout mice
128. Core pathology lab findings in 425 patients undergoing directional atherectomy for a primary coronary artery stenosis and relationship to subsequent outcome: The CAVEAT study
129. Integrins and anoikis
130. Disruption of endothelial cell matrix interactions induces apoptosis
131. Proliferative activity in peripheral and coronary atherosclerotic plaque among patients undergoing percutaneous revascularization
132. Heat shock induces IkappaB-alpha and prevents stress-induced endothelial cell apoptosis
133. Kinetics of cellular proliferation after arterial injury, I: Smooth muscle growth in the absence of endothelium
134. NF-kB is induced in the nuclei of cultured rat aortic smooth muscle cells by stimulation of various growth factors
135. Complex causes of fatal myocardial infarction
136. Use of human tissue specimens obtained by directional atherectomy to study restenosis
137. Histopathology of instent restenosis in patients with peripheral artery disease
138. Reduction of restenosis after angioplasty in an atheromatous rabbit model by suicide gene therapy
139. Involvement of CD95/Apo-1/Fas in cell death after myocardial infarction
140. Inhibition of apoptosis induced by ischaemia reperfusion prevents inflammation
141. The cardiac Fas (APO-1/CD95) receptor/Fas ligand system
142. Tumour necrosis factor-(contributes to ischaemia- and reperfusion induced endothelial dysfunction in isolated hearts
143. Two distinct cytokines released from a human aminoacyl-t-RNA synthase
144. Pro and anti-inflammatory mechanisms in renal reperfusion in mice: Modulation by endogenous tumour necrosis factor alpha and interleukin 10